opioids

Pain, Opioids, Addiction, and Worker Wellness

24 May 2023

Online

This session will focus on substance use and pain with an occupational health lens, addressing worker wellness, the return-to-work process, and the role of the clinician, as well as employer engagement in promoting employee wellbeing.

Global trends in opioid medicine availability

Video and audio recordings

This webinar presented the latest global and regional trends in the use of opioid analgesics and explore issues related to availability. Around the world the consumption of opioid analgesics has been increasing, yet millions of people still...

Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes

Scientific article

28 July 2022

Abstract Background Virtually delivered healthcare (telehealth, telemedicine) has the potential to reduce gaps in access to opioid agonist therapy (OAT). Barriers to accessing OAT such as lack of transportation, in-person induction...

Association of Methamphetamine and Opioid Use With Nonfatal Overdose in Rural Communities

Scientific article

15 August 2022

Abstract Importance Overdoses continue to increase in the US, but the contribution of methamphetamine use is understudied in rural communities. Objective To estimate the prevalence of methamphetamine use and its correlates among people who...

Opioid Facts and Figures

Video and audio recordings

Opioid Facts and Figures, recorded 3-June-2022. Presented by Lauran Wirf, DO: Addiction Medicine Fellow; University of Colorado School of Medicine; Denver, Colorado. With the increasing prevalence of illicit fentanyl, it is important for...

Modeling the evolution of the US opioid crisis for national policy development

Scientific article

7 June 2022

Abstract The opioid crisis is a major public health challenge in the United States, killing about 70,000 people in 2020 alone. Long delays and feedbacks between policy actions and their effects on drug-use behavior create dynamic complexity...

Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial

Scientific article

Abstract Background Increasing buprenorphine/naloxone (B/N) access for opioid use disorder (OUD) is essential yet ensuring adherence and preventing diversion remains challenging. This study examines the feasibility, usability, and...

Opioid Use Disorder in the Nursing Profession

Video and audio recordings

Presented by Kristin Waite-Labott, RN, BSN, CARN; April Lynn Lenzmeier, RN, DNP; Rachel Shuster, BSN, RN, CARN, CAAP. The American Nurses Association estimates that six to eight percent of nurses use alcohol or drugs to an extent that is...

Promoting sustainable responses to the US opioid epidemic with community-academic partnerships: qualitative outcomes from a statewide program

Scientific article

7 April 2022

Abstract Background Drug overdose deaths in the United States have continued to increase at an alarming rate. The Substance Abuse and Mental Health Services Administration (SAMHSA) distributed more than $7 billion between January 2016 and...

Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community

Scientific article

7 March 2022

Abstract Background Medication treatment for opioid use disorder (OUD) (MOUD; buprenorphine and methadone) reduces opioid use and overdose. Discontinuation of MOUD can quickly lead to relapse, overdose and death. Few persons who initiate...